Barriers and Facilitators Associated With Vaccine Acceptance and Uptake Among Pregnant Women in High Income Countries: A Mini-Review.
TLDR
In this article, a mini-review of recent studies in high-income countries on the uptake of influenza and pertussis vaccination in pregnancy, reasons for vaccine hesitancy and barriers to increasing uptake, from maternal and healthcare provider (HCP) perspectives.Abstract:
Vaccination during pregnancy is a safe and effective intervention to protect women from potentially severe consequences of influenza and reduce risk of influenza and pertussis in their infants. However, coverage remains variable. In this mini-review we update findings from a 2015 systematic review to describe results from recent studies in high income countries on the uptake of influenza and pertussis vaccination in pregnancy, reasons for vaccine hesitancy and barriers to increasing uptake, from maternal and healthcare provider (HCP) perspectives. Studies reported highly variable uptake (from 0% to 78%). A main facilitator for uptake among pregnant women was receiving a recommendation from their HCP. However, studies showed that HCP awareness of guidelines did not consistently translate into them recommending vaccines to pregnant women. Safety concerns are a well-established barrier to uptake/coverage of maternal immunization; 7%-52% of unvaccinated women gave safety concerns as a reason but these were also present in vaccinated women. Knowledge/awareness gaps among pregnant women and lack of confidence among HCPs to discuss vaccination were both important barriers. Several studies indicated that midwives were more likely to express safety concerns than other HCPs, and less likely to recommend vaccination to pregnant women. Women who perceived the risk of infection to be low were less likely to accept vaccination in several studies, along with women with prior vaccine refusal. Findings highlight the importance of further research to explore context-specific barriers to vaccination in pregnancy, which may include lack of vaccine confidence among pregnant woman and HCPs, and policy and structural factors.read more
Citations
More filters
Journal ArticleDOI
COVID-19 vaccine hesitancy among pregnant women: a systematic review and meta-analysis
TL;DR: Overall, COVID-19 vaccine acceptance among pregnant women was low across the studies and considerably low among some specific subgroups of participants, and these research findings have implications for the development of effective interventions that could increase the CO VID- 19 vaccine acceptance level among pregnantWomen to attain herd immunity.
Journal ArticleDOI
Monkeypox in pregnancy: virology, clinical presentation, and obstetric management
Pradip Dashraath,Karin Nielsen-Saines,Anne W. Rimoin,Citra Nurfarah Zaini Mattar,Alice Panchaud,David Baud +5 more
TL;DR: In this article , the impact of monkeypox infection on maternal, fetal, and neonatal health is discussed, including the risks of heart rate-corrected QT-interval prolongation, inaccuracies in blood glucose monitoring, and the predisposition to iatrogenic venous thromboembolism.
Journal ArticleDOI
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Susanna Esposito,Bahaa Abu Raya,Eugenio Baraldi,Katie L. Flanagan,F. Martinón Torres,Maria Tsolia,Stefan Zielen +6 more
TL;DR: It is concluded that, based on current data, immunization of infants with long-acting mAbs might represent the most effective approach for protecting all infants entering their first RSV season.
Journal ArticleDOI
Oxford COVID-19 Vaccine Hesitancy in School Principals: Impacts of Gender, Well-Being, and Coronavirus-Related Health Literacy.
Tuyen Van Duong,Cheng Yu Lin,Sheng Chih Chen,Yung Kai Huang,Orkan Okan,Kevin Dadaczynski,Chih Feng Lai +6 more
TL;DR: In this paper, the authors explored the associated factors of vaccine hesitancy and examined psychometric properties of the coronavirus-related health literacy questionnaire (HLS-COVID-Q22) and Oxford COVID-19 Vaccine Hesitancy questionnaire.
Journal ArticleDOI
Comprehensive Overview of Vaccination during Pregnancy in Europe.
Anca A. Simionescu,Anca Streinu-Cercel,Florin-Dan Popescu,Ana Maria Alexandra Stănescu,Mariana Vieru,Bianca Danciu,Victor Daniel Miron,Oana Săndulescu +7 more
TL;DR: In this article, the authors present the current knowledge on vaccination during pregnancy in Europe as a useful information source for different health workers involved in prenatal care and make recommendations based on current high-quality scientific data.
References
More filters
Journal ArticleDOI
Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.
TL;DR: The results show a variety of factors as being associated with vaccine hesitancy but they do not allow for a complete classification and confirmation of their independent and relative strength of influence.
Journal ArticleDOI
Effectiveness of maternal influenza immunization in mothers and infants.
K. Zaman,Eliza Roy,Shams El Arifeen,Mahbubur Rahman,Rubhana Raqib,Emily Wilson,Saad B. Omer,Nigar S. Shahid,Robert F. Breiman,Mark C. Steinhoff +9 more
TL;DR: Inactivated influenza vaccine reduced proven influenza illness by 63% in infants up to 6 months of age and averted approximately a third of all febrile respiratory illnesses in mothers and young infants in Bangladesh.
Journal ArticleDOI
Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review
TL;DR: Barriers to vaccination in pregnancy are complex and vary depending on context and population; there are wide gaps in knowledge regarding the attitudes of healthcare workers and how ethnicity and gender dynamics influence a pregnant woman's decision to vaccinate.
Journal ArticleDOI
Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.
Brigitte Keller-Stanislawski,Janet A. Englund,Gagandeep Kang,Punam Mangtani,Kathleen M. Neuzil,Kathleen M. Neuzil,Hanna Nohynek,Robert Pless,Philipp Lambach,Patrick L.F. Zuber +9 more
TL;DR: Safety data were reviewed for vaccines against diseases which increase morbidity in pregnant women, their fetus or infant as well as vaccines which are used in mass vaccination campaigns against diseases.
Journal ArticleDOI
Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns
TL;DR: The proposed indicators provide the first global snapshot of reasons driving vaccine hesitancy and depicting its widespread nature, as well as the extent of assessments conducted by countries.